Viemed Healthcare (VMD) EBIT (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.68% |
| Dec 31, 2025 | 48.37% |
| Sep 30, 2025 | 10.74% |
| Jun 30, 2025 | 32.65% |
| Mar 31, 2025 | -40.47% |
| Dec 31, 2024 | 14.64% |
| Sep 30, 2024 | 55.64% |
| Jun 30, 2024 | 64.07% |
| Mar 31, 2024 | -58.33% |
| Dec 31, 2023 | 25.75% |
| Sep 30, 2023 | 44.98% |
| Jun 30, 2023 | 50.00% |
| Mar 31, 2023 | -45.27% |
| Dec 31, 2022 | 140.57% |
| Sep 30, 2022 | 46.75% |
| Jun 30, 2022 | -55.47% |
| Mar 31, 2022 | -51.81% |
| Dec 31, 2021 | 59.82% |
| Sep 30, 2021 | 9.57% |
| Jun 30, 2021 | 100.00% |
| Mar 31, 2021 | -74.71% |
| Dec 31, 2020 | 30.37% |
| Sep 30, 2020 | -68.58% |
| Jun 30, 2020 | 178.63% |
| Mar 31, 2020 | 71.50% |
| Dec 31, 2019 | 23.10% |
| Sep 30, 2019 | 31.37% |
| Jun 30, 2019 | -28.15% |
| Mar 31, 2019 | -20.55% |
| Dec 31, 2018 | 16.09% |
| Sep 30, 2018 | 9.75% |
| Jun 30, 2018 | -2.31% |